CME Group Inc. (NASDAQ:CME) Stock Holdings Lifted by Farther Finance Advisors LLC

Farther Finance Advisors LLC lifted its holdings in shares of CME Group Inc. (NASDAQ:CME) by 56.6% in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 6,195 shares of the financial services provider’s stock after buying an additional 2,239 shares during the period. Farther Finance Advisors LLC’s holdings in CME Group were worth $1,211,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently bought and sold shares of CME. Gold Investment Management Ltd. acquired a new stake in shares of CME Group during the 4th quarter worth approximately $26,000. Northwest Financial Advisors acquired a new stake in CME Group in the fourth quarter worth $28,000. Salomon & Ludwin LLC bought a new stake in CME Group in the first quarter valued at $28,000. McClarren Financial Advisors Inc. lifted its stake in CME Group by 66.1% in the second quarter. McClarren Financial Advisors Inc. now owns 196 shares of the financial services provider’s stock valued at $39,000 after buying an additional 78 shares during the last quarter. Finally, Rise Advisors LLC acquired a new position in shares of CME Group during the first quarter valued at $41,000. Institutional investors and hedge funds own 87.75% of the company’s stock.

Analysts Set New Price Targets

A number of research firms recently weighed in on CME. Barclays increased their price objective on shares of CME Group from $208.00 to $209.00 and gave the stock an “equal weight” rating in a report on Thursday, July 25th. Piper Sandler restated an “overweight” rating and issued a $225.00 price target on shares of CME Group in a research note on Tuesday, August 20th. Keefe, Bruyette & Woods boosted their price objective on CME Group from $212.00 to $213.00 and gave the stock a “market perform” rating in a research report on Thursday, July 25th. Deutsche Bank Aktiengesellschaft raised their target price on CME Group from $193.00 to $200.00 and gave the company a “hold” rating in a research report on Thursday, August 15th. Finally, JPMorgan Chase & Co. boosted their price target on CME Group from $187.00 to $191.00 and gave the stock an “underweight” rating in a research report on Thursday, July 25th. Three equities research analysts have rated the stock with a sell rating, six have assigned a hold rating and three have given a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $213.27.

CME Group Trading Up 0.8 %

Shares of CME stock opened at $215.74 on Monday. The stock has a 50-day simple moving average of $201.36 and a 200 day simple moving average of $207.38. The stock has a market capitalization of $77.68 billion, a P/E ratio of 24.54, a P/E/G ratio of 6.51 and a beta of 0.52. CME Group Inc. has a fifty-two week low of $190.70 and a fifty-two week high of $223.80. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.10.

CME Group (NASDAQ:CME) last posted its quarterly earnings data on Wednesday, July 24th. The financial services provider reported $2.56 earnings per share for the quarter, beating the consensus estimate of $2.53 by $0.03. CME Group had a net margin of 56.98% and a return on equity of 12.82%. The company had revenue of $1.53 billion during the quarter, compared to analyst estimates of $1.53 billion. During the same quarter last year, the firm posted $2.30 EPS. The business’s revenue for the quarter was up 12.7% on a year-over-year basis. On average, sell-side analysts expect that CME Group Inc. will post 9.89 earnings per share for the current fiscal year.

CME Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, September 25th. Shareholders of record on Monday, September 9th will be issued a $1.15 dividend. The ex-dividend date is Monday, September 9th. This represents a $4.60 annualized dividend and a dividend yield of 2.13%. CME Group’s dividend payout ratio is currently 52.33%.

Insider Buying and Selling at CME Group

In other news, Director Charles P. Carey sold 3,000 shares of the firm’s stock in a transaction on Thursday, June 13th. The stock was sold at an average price of $195.44, for a total transaction of $586,320.00. Following the completion of the sale, the director now directly owns 7,163 shares of the company’s stock, valued at approximately $1,399,936.72. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. In other CME Group news, Director Charles P. Carey sold 3,000 shares of the company’s stock in a transaction dated Thursday, June 13th. The shares were sold at an average price of $195.44, for a total transaction of $586,320.00. Following the completion of the sale, the director now directly owns 7,163 shares of the company’s stock, valued at $1,399,936.72. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, Director Daniel R. Glickman sold 650 shares of CME Group stock in a transaction that occurred on Thursday, June 6th. The stock was sold at an average price of $201.44, for a total transaction of $130,936.00. Following the completion of the transaction, the director now directly owns 14,008 shares in the company, valued at $2,821,771.52. The disclosure for this sale can be found here. 0.30% of the stock is owned by corporate insiders.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.